Masayuki Muto Selected Research

histidylproline

7/2020

Effective treatment of relapsed prostate small cell carcinoma with amrubicin: report of a case.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Muto Research Topics

Disease

2	Neoplasm Metastasis (Metastasis) 07/2020 - 07/2019
1	Pneumonia (Pneumonitis) 07/2020
1	Prostatic Neoplasms (Prostate Cancer) 07/2020
1	Small Cell Carcinoma 07/2020
1	Fistula 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2019
1	Abdominal Pain (Pain, Abdominal) 11/2019
1	Pneumatosis Cystoides Intestinalis 11/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2018

Drug/Important Bio-Agent (IBA)

1	amrubicinIBA 07/2020
1	histidylprolineIBA 07/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2020
1	Cisplatin (Platino)FDA LinkGeneric 07/2020
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 07/2020
1	Gastrin-Releasing PeptideIBA 07/2020
1	EnbucrilateIBA 01/2020
1	Sunitinib (Sutent)FDA Link 11/2019
1	Tyrosine Kinase InhibitorsIBA 11/2019
1	Rocuronium (Zemuron)FDA LinkGeneric 01/2018
1	SugammadexIBA 01/2018
1	Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric 01/2018

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 07/2020
1	Therapeutics 07/2020
1	Nephrectomy 07/2019